Kim BY - Search Results

1

Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas.

Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI, Beadle BM, Frank SJ, Morrison WH, El-Naggar AK, Glisson BS, Sturgis EM, Phan J. Jiang W, et al. Among authors: kim by. Head Neck. 2016 Apr;38 Suppl 1(Suppl 1):E1459-66. doi: 10.1002/hed.24258. Epub 2015 Nov 11. Head Neck. 2016. PMID: 26560893 Free PMC article.

2

Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing.

Kim BYS, Jiang W, Beiko J, Prabhu SS, DeMonte F, Gilbert MR, Sawaya R, Aldape KD, Cahill DP, McCutcheon IE. Kim BYS, et al. J Neurooncol. 2014 Jun;118(2):405-412. doi: 10.1007/s11060-014-1451-0. Epub 2014 Apr 29. J Neurooncol. 2014. PMID: 24777756 Free PMC article.

3

Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles.

Jiang W, Huang Y, An Y, Kim BY. Jiang W, et al. Among authors: kim by. ACS Nano. 2015 Sep 22;9(9):8689-96. doi: 10.1021/acsnano.5b02028. Epub 2015 Jul 31. ACS Nano. 2015. PMID: 26212564

4

Non-contiguous meningeal metastases of olfactory neuroblastoma.

Jiang W, Liu J, Gullane PJ, Gentili F, Wharen RE, Kim BYS, DeMonte F. Jiang W, et al. J Neurooncol. 2016 Jan;126(1):201-203. doi: 10.1007/s11060-015-1935-6. Epub 2015 Sep 16. J Neurooncol. 2016. PMID: 26376653

5

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.

Liu J, Mao K, Jiang S, Jiang W, Chen K, Kim BY, Liu Q, Jacobs LK. Liu J, et al. Among authors: kim by. Oncotarget. 2016 Apr 26;7(17):24848-59. doi: 10.18632/oncotarget.6664. Oncotarget. 2016. PMID: 26709538 Free PMC article.

6

The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.

Jiang W, Mohamed ASR, Fuller CD, Kim BYS, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. Jiang W, et al. Pract Radiat Oncol. 2016 Jul-Aug;6(4):241-247. doi: 10.1016/j.prro.2015.10.023. Epub 2015 Nov 10. Pract Radiat Oncol. 2016. PMID: 26979544 Free PMC article.

7

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.

Qie Y, Yuan H, von Roemeling CA, Chen Y, Liu X, Shih KD, Knight JA, Tun HW, Wharen RE, Jiang W, Kim BY. Qie Y, et al. Among authors: kim by. Sci Rep. 2016 May 19;6:26269. doi: 10.1038/srep26269. Sci Rep. 2016. PMID: 27197045 Free PMC article.

8

Breaking Down the Barriers to Precision Cancer Nanomedicine.

von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BYS. von Roemeling C, et al. Trends Biotechnol. 2017 Feb;35(2):159-171. doi: 10.1016/j.tibtech.2016.07.006. Epub 2016 Aug 1. Trends Biotechnol. 2017. PMID: 27492049 Review.

9

Lessons from immuno-oncology: a new era for cancer nanomedicine?

Jiang W, Yuan H, Chan CK, von Roemeling CA, Yan Z, Weissman IL, Kim BYS. Jiang W, et al. Nat Rev Drug Discov. 2017 Jun;16(6):369-370. doi: 10.1038/nrd.2017.34. Epub 2017 Mar 17. Nat Rev Drug Discov. 2017. PMID: 28303024

10

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy.

Yuan H, Jiang W, von Roemeling CA, Qie Y, Liu X, Chen Y, Wang Y, Wharen RE, Yun K, Bu G, Knutson KL, Kim BYS. Yuan H, et al. Nat Nanotechnol. 2017 Aug;12(8):763-769. doi: 10.1038/nnano.2017.69. Epub 2017 May 1. Nat Nanotechnol. 2017. PMID: 28459470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,356 results

Search Page

Filters